Top 100 Pharmaceutical Enterprises and Top 10 R&D Pipeline Awards

pharma.com/back/edit/uploadfile/2009021261.jpg">

On August 18th, the 27th Annual Meeting of National Medical and Pharmaceutical        Industry Information held in

Shanghai. Meanwhile, they announced that Qilu pharma ranks 18th in “Top 100 Pharmaceutical Enterprises”, and one of “Top 10 Industry Enterprises with best R&D pipeline”, which is the only award that be accepted by China Medicine Tender. Mr. Wang Jingyi, the director of R&D Institute attends the meeting and accepts the awards

The two awards demonstrate that the industry have strong confidence in Qilu’s comprehensive competitive power and R&D capability of new product and also show Qilu’s great potentials of fast developing with the support of powerful R&D team.